NCT06562647 2026-02-13
SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid Tumors
Cell Origin Biotech (Hangzhou) Co., Ltd.
Phase NA Recruiting
Cell Origin Biotech (Hangzhou) Co., Ltd.
University of Kentucky
Hamilton Health Sciences Corporation
The Hospital for Sick Children
Hospital del Mar
The Hospital for Sick Children
Chang Gung Memorial Hospital
Ludwig-Maximilians - University of Munich